I-SENS acquires U.S. diagnostic device company ‘CoaguSense’
On the 22nd, a biosensor company, I-SENS(CEO Geun-Sig Cha), signed an agreement to acquire 62% of the share of a U.S. blood coagulation monitoring company ‘CoaguSense’ and its control for USD 10.4 million.
According to I-SENS, CoaguSense is a company specializing in monitoring blood coagulation ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
